| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 59.56B | 46.69B | 34.73B | 19.61B | 12.21B | 17.75B |
| Gross Profit | 17.98B | 35.26B | 25.15B | 10.50B | 2.71B | 5.90B |
| EBITDA | 45.12B | 39.91B | 29.12B | 14.77B | 6.44B | 11.31B |
| Net Income | 29.50B | 28.04B | 19.95B | 6.09B | -2.59B | 1.05B |
Balance Sheet | ||||||
| Total Assets | 675.15B | 680.00B | 563.39B | 494.24B | 494.82B | 516.49B |
| Cash, Cash Equivalents and Short-Term Investments | 42.80B | 31.96B | 21.96B | 15.55B | 12.76B | 21.21B |
| Total Debt | 318.45B | 323.20B | 269.10B | 240.80B | 244.94B | 262.59B |
| Total Liabilities | 323.78B | 328.62B | 273.09B | 243.92B | 248.69B | 266.85B |
| Stockholders Equity | 351.36B | 351.39B | 290.31B | 250.32B | 246.13B | 249.64B |
Cash Flow | ||||||
| Free Cash Flow | -60.42B | -72.80B | -33.62B | 10.86B | 11.73B | 7.30B |
| Operating Cash Flow | 40.31B | 37.80B | 26.56B | 12.40B | 12.82B | 26.17B |
| Investing Cash Flow | -113.54B | -111.26B | -57.52B | -1.57B | -2.75B | -20.69B |
| Financing Cash Flow | 73.48B | 83.85B | 45.33B | -7.03B | -19.52B | -8.09B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥43.16B | 9.20 | ― | 10.55% | 75.37% | 134.79% | |
76 Outperform | ¥460.26B | 19.39 | 9.29% | 4.34% | 36.94% | 37.79% | |
71 Outperform | €531.43B | 18.01 | 9.62% | 5.62% | 19.85% | 8.60% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
66 Neutral | ¥151.32B | 27.03 | ― | 3.99% | 23.80% | 7.98% | |
64 Neutral | ¥633.49B | 22.49 | ― | 4.44% | 27.21% | 39.13% |